Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell Type

Preferred Label : Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell Type;

NCIt synonyms : Refractory Non-GC/ABC DLBCL; Refractory Diffuse Large B-Cell Lymphoma Non-GC/ABC; Refractory Diffuse Large B-Cell Lymphoma Non-Germinal Center/Activated B-Cell Type;

NCIt definition : Diffuse large B-cell lymphoma activated B-cell type that is resistant to treatment.;

Neoplastic status : Malignant;

NCI Metathesaurus CUI : CL969318;

Détails

Origin ID

C160239;

UMLS CUI

C5205066;

Disease excludes abnormal cell
- Lymphocyte Predominant Cell [NCIt concept]
- Neoplastic T-Lymphocyte and Neoplastic Natural Killer Cell [NCIt concept]
- Plasmablastic Immunoblast [NCIt concept]
- Reed-Sternberg Cell [NCIt concept]
Disease excludes normal cell origin
- Myeloid Cell [NCIt concept]
- Plasma Cell [NCIt concept]
- Precursor B-Lymphoblast [NCIt concept]
- Thymic B-Lymphocyte [NCIt concept]
Disease may have findings
- Aggressive Clinical Course [NCIt concept]
- Lymphadenopathy [NCIt concept]
Excludes anatomical site(s)
- Thymus Gland [NCIt concept]
- Vascular System [NCIt concept]
Has associated anatomic sites
- Hematopoietic and Lymphatic System [NCIt concept]
Semantic type(s)
- Neoplastic Process [UMLS semantic type]
concept_is_in_subset
- CTRP Disease Terminology [NCIt concept]
- CTRP Terminology [NCIt concept]
disease_excludes_finding
- Benign Cellular Infiltrate [NCIt concept]
- Histiocytosis [NCIt concept]
disease_excludes_molecular_abnormality
- ALK Kinase Overexpression [NCIt concept]
disease_has_abnormal_cell
- Abnormal Lymphocyte [NCIt concept]
- Malignant Cell [NCIt concept]
- Neoplastic B-Lymphocyte [NCIt concept]
- Neoplastic Cell [NCIt concept]
- Neoplastic Hematopoietic and Lymphoid Cell [NCIt concept]
- Neoplastic Large B-Lymphocyte [NCIt concept]
- Neoplastic Lymphocyte [NCIt concept]
disease_has_finding
- Diffuse Pattern [NCIt concept]
- Increased NFkappaB Pathway Activation [NCIt concept]
- Malignant Cellular Infiltrate [NCIt concept]
- Not Otherwise Specified Lesion [NCIt concept]
- Refractory Disease [NCIt concept]
disease_has_molecular_abnormality
- BCL2 mRNA Overexpression [NCIt concept]
- CCND2 mRNA Overexpression [NCIt concept]
- CD44 mRNA Overexpression [NCIt concept]
- Clonal Immunoglobulin Gene Rearrangement [NCIt concept]
- Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement [NCIt concept]
- IRF4 mRNA Overexpression [NCIt concept]
- PRKCB mRNA Overexpression [NCIt concept]
disease_has_normal_cell_origin
- Activated B-Lymphocyte [NCIt concept]
- B-Lymphocyte [NCIt concept]
- Hematopoietic and Lymphoid Cell [NCIt concept]
- Lymphocyte [NCIt concept]
- Mature B-Lymphocyte [NCIt concept]
disease_has_normal_tissue_origin
- Hematopoietic and Lymphoid Tissue [NCIt concept]
- Lymphoid Tissue [NCIt concept]
disease_has_primary_anatomic_site
- Hematopoietic and Lymphatic System [NCIt concept]
- Lymphatic System [NCIt concept]
disease_may_have_abnormal_cell
- Neoplastic B-Immunoblast [NCIt concept]
- Neoplastic Centroblast [NCIt concept]
disease_may_have_associated_disease
- Centroblastic Lymphoma [NCIt concept]
- Immunoblastic Lymphoma [NCIt concept]
disease_may_have_molecular_abnormality
- Clonal Immunoglobulin Heavy Chain Gene Rearrangement [NCIt concept]
- Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients